Drug intelligence / Profile preview

clobetasol propionate + miconazole nitrate + neomycin sulphate

Development stage
Unknown
Lead developer
Oscorp Remedies
Modality
Small Molecules
Administration
Topical
01

Overview

Ricoderm-GN is a topical combination medication developed by Oscorp Remedies, designed to treat inflammatory skin conditions complicated by bacterial and fungal infections. The formulation contains clobetasol propionate, a high-potency corticosteroid that provides rapid relief from inflammation, redness, and itching; neomycin sulphate, an aminoglycoside antibiotic that addresses secondary bacterial infections; and miconazole nitrate, an imidazole antifungal agent effective against a broad spectrum of fungi. This triple-action approach makes Ricoderm-GN suitable for managing complex dermatological conditions such as infected eczema, psoriasis, and various forms of dermatitis where a multi-pronged therapeutic strategy is required.

Brand names
Ricoderm-GN
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on clobetasol propionate + miconazole nitrate + neomycin sulphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol propionate + miconazole nitrate + neomycin sulphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call